SCHEMBL265667

SCHEMBL265667

CCN(NCc1ccc(O)cc1)C(=O)c1ccc(C(=O)CNCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)s1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 19/20 0.53
CHRM2 P08172 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL268484 0.88 CHRM3 (0.53) CHRM3CHRM2
SCHEMBL3761050 0.86 CHRM3 (0.53) CHRM3
SCHEMBL710631 0.86 CHRM3 (0.59) CHRM3
SCHEMBL265767 0.85 CHRM3 (0.51) CHRM3
SCHEMBL3761046 0.83 CHRM3 (0.52) CHRM3
SCHEMBL5278240 0.83 CHRM3 (0.52) CHRM3CHRM2
SCHEMBL714031 0.82 CHRM3 (0.53) CHRM3CHRM2
SCHEMBL3763192 0.82 CHRM3 (0.59) CHRM3
SCHEMBL645761 0.82 CHRM3 (0.59) CHRM3
SCHEMBL3301257 0.81 CHRM3 (0.52) CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133905-B2 Biphenyl compounds useful as muscarinic receptor antagonists THERAVANCE, INC. (US) 2012-03-13 US disclosed
US-8124627-B2 Biphenyl compounds useful as muscarinic receptor antagonists THERAVANCE, INC. (US) 2012-02-28 US disclosed